SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-20-004711
Filing Date
2020-02-25
Accepted
2020-02-25 12:41:46
Documents
5
Period of Report
2020-02-25

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea119006-6k_biondvax.htm 6-K 21595
2 NOTICE AND PROXY STATEMENT ea119006ex99-1_biondvax.htm EX-99.1 166070
3 PROXY CARD ea119006ex99-2_biondvax.htm EX-99.2 1688
4 GRAPHIC ex99-2_001.jpg GRAPHIC 379240
5 GRAPHIC ex99-2_002.jpg GRAPHIC 290485
  Complete submission text file 0001213900-20-004711.txt   1113078
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37353 | Film No.: 20649174
SIC: 2836 Biological Products, (No Diagnostic Substances)